While MDS shares some genetic features with CHIP, such as mutations in epigenetic regulators, it also exhibits cytogenetic aberrations and additional mutations, especially in RNA splicing factors (SF3B1, SRSF2, ZRSR2)15,16. Here, SRSF2 is linked to myelodysplastic syndrome.